XML 54 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Shared-Based Compensation
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Shared-Based Compensation

Note 9.     Shared-Based Compensation

During the three month periods ended March 31, 2015 and 2014, approximately $783 and $539 respectively, of compensation expense was recognized in selling, general and administrative expense for all share-based awards. During the three month period ended March 31, 2015, there were 67 restricted stock awards to non-executive directors, officers and certain other key employees. During the three month period ended March 31, 2014, there were 93 restricted stock awards and 96 options awards to non-executive directors, officers and certain other key employees.

The restricted shares granted during the three month period ended March 31, 2015, vest pro-rata over three years for officers and certain other key employees and over one year for non-executive directors. The restricted shares granted during the three month period ended March 31, 2014, vest pro-rata over three years. During the three month periods ended March 31 2015 and 2014, we incurred $468 and $162, respectively, in expense related to restricted stock. The fair value of the shares issued was determined by using the grant date closing price of our common stock.

We incurred $315 and $377 of stock option expense in the three month periods ended March 31, 2015 and 2014, respectively. The fair value of our options cannot be determined by market value, because our options are not traded in an open market. Accordingly, we utilized the Black Scholes financial pricing model to estimate the fair value.

The following table provides a reconciliation of option activity for the three month period ended March 31, 2015:

 

Options

   Shares (000)     Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual
Term
     Aggregate
Intrinsic Value
($000)
 

Outstanding at January 1, 2015

     1,175      $ 11.40         

Granted

     —        $ —           

Exercised

     (14   $ 11.22         

Forfeited or expired

     —        $ —           
  

 

 

         

Outstanding at March 31, 2015

  1,161    $ 11.40      6.0    $ 15,884 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at March 31, 2015

  952    $ 10.94      5.4    $ 13,462 (1) 
  

 

 

   

 

 

    

 

 

    

 

 

 

 

(1)  The intrinsic value is the amount by which the market price of our stock was greater than the exercise price of any individual option grant at March 31, 2015.